These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22113625)

  • 1. Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.
    Frieri M
    Curr Allergy Asthma Rep; 2012 Feb; 12(1):25-32. PubMed ID: 22113625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
    Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
    Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accelerated atherosclerosis and inflammation in systemic lupus erythematosus].
    Funakubo Asanuma Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(6):470-80. PubMed ID: 23291482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
    Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
    PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation.
    Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus.
    Richez C; Richards RJ; Duffau P; Weitzner Z; Andry CD; Rifkin IR; Aprahamian T
    PLoS One; 2013; 8(4):e61042. PubMed ID: 23577189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Atherosclerosis in systemic lupus erythematosus].
    Tazi Mezalek Z; Harmouche H; Ammouri W; Maamar M; Adnaoui M; Cacoub P
    Presse Med; 2014 Oct; 43(10 Pt 1):1034-47. PubMed ID: 25201598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.
    Aprahamian T; Bonegio R; Rizzo J; Perlman H; Lefer DJ; Rifkin IR; Walsh K
    J Immunol; 2006 Sep; 177(5):3028-34. PubMed ID: 16920939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).
    Colombo BM; Cacciapaglia F; Puntoni M; Murdaca G; Rossi E; Rodriguez G; Nobili F; Pisciotta L; Bertolini S; Moccetti T; Dentali F; Steidl L; Ciprandi G; Afeltra A; Indiveri F; Puppo F
    Autoimmun Rev; 2009 Feb; 8(4):309-15. PubMed ID: 18976721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
    Patiño-Trives AM; Pérez-Sánchez C; Pérez-Sánchez L; Luque-Tévar M; Ábalos-Aguilera MC; Alcaide-Ruggiero L; Arias-de la Rosa I; Román-Rodríguez C; Seguí P; Espinosa M; Font P; Barbarroja N; Escudero-Contreras A; Antonio González-Reyes J; Manuel Villalba J; Collantes-Estévez E; Aguirre-Zamorano MÁ; López-Pedrera C
    Arterioscler Thromb Vasc Biol; 2021 Sep; 41(9):2417-2430. PubMed ID: 34320837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of macrophage autophagy ameliorates activated lymphocytes-derived DNA induced murine lupus possibly via inhibition of proinflammatory cytokine production.
    Li B; Yue Y; Dong C; Shi Y; Xiong S
    Clin Exp Rheumatol; 2014; 32(5):705-14. PubMed ID: 25151985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lupus nephritis: review of the literature.
    Zubair A; Frieri M
    Curr Allergy Asthma Rep; 2013 Dec; 13(6):580-6. PubMed ID: 24234325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.
    Reiss AB; Jacob B; Ahmed S; Carsons SE; DeLeon J
    Inflammation; 2021 Oct; 44(5):1663-1682. PubMed ID: 33821395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.
    Thacker SG; Berthier CC; Mattinzoli D; Rastaldi MP; Kretzler M; Kaplan MJ
    J Immunol; 2010 Oct; 185(7):4457-69. PubMed ID: 20805419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient.
    Smrzova A; Horak P; Skacelova M; Hermanova Z; Langova K; Zadrazil J; Novotny D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):404-11. PubMed ID: 23945845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; Borozdenkova S; Karim MY
    Nephrol Dial Transplant; 2011 Oct; 26(10):3273-80. PubMed ID: 21372259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.
    Tu H; Li Q; Xiang S; Jiang H; Mao Y; Shou Z; Chen J
    Atherosclerosis; 2012 May; 222(1):29-33. PubMed ID: 22417842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis and treatment of atherosclerosis in lupus.
    McMahon M; Skaggs B
    Rheum Dis Clin North Am; 2014 Aug; 40(3):475-95, viii. PubMed ID: 25034157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.